ProShare Advisors’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-24,385
Closed -$439K 1715
2020
Q2
$439K Buy
24,385
+7,955
+48% +$143K ﹤0.01% 1018
2020
Q1
$117K Sell
16,430
-12,414
-43% -$88.4K ﹤0.01% 1064
2019
Q4
$689K Sell
28,844
-2,318
-7% -$55.4K ﹤0.01% 936
2019
Q3
$836K Buy
31,162
+2,723
+10% +$73.1K ﹤0.01% 810
2019
Q2
$772K Sell
28,439
-3,878
-12% -$105K ﹤0.01% 857
2019
Q1
$1.12M Buy
32,317
+994
+3% +$34.5K 0.01% 720
2018
Q4
$611K Sell
31,323
-5,924
-16% -$116K ﹤0.01% 878
2018
Q3
$992K Sell
37,247
-555
-1% -$14.8K 0.01% 822
2018
Q2
$1.43M Sell
37,802
-1,309
-3% -$49.4K 0.01% 711
2018
Q1
$1.28M Sell
39,111
-6,244
-14% -$204K 0.01% 744
2017
Q4
$2.21M Buy
45,355
+7,572
+20% +$369K 0.02% 585
2017
Q3
$2.04M Buy
37,783
+2,935
+8% +$159K 0.02% 554
2017
Q2
$1.96M Sell
34,848
-2,203
-6% -$124K 0.02% 566
2017
Q1
$1.45M Sell
37,051
-9,027
-20% -$354K 0.02% 648
2016
Q4
$1.03M Buy
46,078
+3,978
+9% +$89.3K 0.01% 758
2016
Q3
$956K Sell
42,100
-7,833
-16% -$178K 0.01% 695
2016
Q2
$1.18M Buy
49,933
+875
+2% +$20.6K 0.02% 670
2016
Q1
$1M Sell
49,058
-2,685
-5% -$54.8K 0.01% 699
2015
Q4
$2.66M Buy
51,743
+5,324
+11% +$274K 0.03% 421
2015
Q3
$1.98M Sell
46,419
-999
-2% -$42.6K 0.03% 481
2015
Q2
$2.16M Sell
47,418
-1
-0% -$46 0.03% 489
2015
Q1
$1.8M Buy
47,419
+6,050
+15% +$230K 0.02% 595
2014
Q4
$1.17M Buy
41,369
+5,393
+15% +$153K 0.01% 783
2014
Q3
$909K Sell
35,976
-6,963
-16% -$176K 0.01% 1105
2014
Q2
$1.25M Buy
42,939
+1,496
+4% +$43.7K 0.02% 1053
2014
Q1
$1.07M Buy
41,443
+23,224
+127% +$601K 0.01% 1253
2013
Q4
$469K Buy
+18,219
New +$469K 0.01% 1078